Agilon Health Inc (AGL)
4.48 unch (unch) 03/25/25 [NYSE]
4.32 x 700 4.50 x 500
Realtime by (Cboe BZX)
4.32 x 700 4.50 x 500
Realtime 4.32 -0.16 (-3.57%) 16:13 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 193,860 | 153,790 | 116,336 | 118,550 | 114,329 |
Marketable Securities | 211,737 | 244,766 | 291,622 | 307,359 | 380,773 |
Receivables | 1,017,040 | 1,368,349 | 1,437,040 | 1,571,143 | 942,461 |
TOTAL | $1,457,774 | $1,811,759 | $1,884,010 | $2,036,809 | $1,480,076 |
Non-Current Assets | |||||
PPE Net | 28,169 | 28,194 | 27,821 | 27,539 | 27,576 |
Intangibles | 96,904 | 97,545 | 98,954 | 96,209 | 87,902 |
Other Non-Current Assets | 151,136 | 153,913 | 152,530 | 155,906 | 145,312 |
TOTAL | $276,209 | $279,652 | $279,305 | $279,654 | $260,790 |
Total Assets | $1,733,983 | $2,091,411 | $2,163,315 | $2,316,463 | $1,740,866 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | 8,750 | 7,500 | N/A |
Accounts payable and accrued liabilities | 1,152,006 | 1,409,157 | 1,378,563 | 1,519,148 | 977,156 |
TOTAL | $1,152,006 | $1,409,157 | $1,387,313 | $1,526,648 | $977,156 |
Non-Current Liabilities | |||||
Long Term Debt | 34,904 | 34,884 | 27,360 | 29,834 | 32,308 |
aiOther Non-Current Liabilities | 76,121 | 72,498 | 72,755 | 71,465 | 70,432 |
TOTAL | $111,025 | $107,382 | $100,135 | $101,329 | $102,689 |
Total Liabilities | $1,263,031 | $1,516,539 | $1,487,448 | $1,627,977 | $1,079,845 |
Shareholders' Equity | |||||
Shares Outstanding, K | 412,303 | 412,018 | 411,483 | 411,262 | 409,542 |
Common Shares | 4,122 | 4,120 | 4,114 | 4,108 | 4,064 |
Retained earnings | -1,586,977 | -1,481,187 | -1,363,572 | -1,332,890 | -1,326,826 |
Other shareholders' equity | -88 | 301 | -3,215 | -3,535 | -3,116 |
TOTAL | $470,952 | $574,872 | $675,867 | $688,486 | $661,021 |
Total Liabilities And Equity | $1,733,983 | $2,091,411 | $2,163,315 | $2,316,463 | $1,740,866 |